These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

101 related items for PubMed ID: 2936824

  • 1. The activation of tumoricidal properties in human blood monocytes by muramyl dipeptide requires specific intracellular interaction.
    Fogler WE, Fidler IJ.
    J Immunol; 1986 Mar 15; 136(6):2311-7. PubMed ID: 2936824
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Abrogation of species specificity for activation of tumoricidal properties in macrophages by recombinant mouse or human interferon-gamma encapsulated in liposomes.
    Fidler IJ, Fogler WE, Kleinerman ES, Saiki I.
    J Immunol; 1985 Dec 15; 135(6):4289-96. PubMed ID: 3934281
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Potentiating effect of muramyl dipeptide and its lipophilic analog encapsulated in liposomes on tumor cell killing by human monocytes.
    Sone S, Mutsuura S, Ogawara M, Tsubura E.
    J Immunol; 1984 Apr 15; 132(4):2105-10. PubMed ID: 6699409
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Comparative interaction of free and liposome-encapsulated nor-muramyl dipeptide or muramyl tripeptide phosphatidylethanolamine (3H-labelled) with human blood monocytes.
    Fogler WE, Fidler IJ.
    Int J Immunopharmacol; 1987 Apr 15; 9(2):141-50. PubMed ID: 3583507
    [Abstract] [Full Text] [Related]

  • 8. [Induction of tumoricidal properties in human monocytes by synergism between interferon-gamma and liposome-entrapped muramyl tripeptide].
    Utsugi T, Sone S, Tandon P, Ogawara M, Shimizu E, Nii A, Nakanishi M, Shono M, Ogura T.
    Gan To Kagaku Ryoho; 1986 Oct 15; 13(11):3161-8. PubMed ID: 3096216
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Potential value of liposomes containing muramyl dipeptide for augmenting the tumoricidal activity of human alveolar macrophages.
    Sone S, Tachibana K, Shono M, Ogushi F, Tsubura E.
    J Biol Response Mod; 1984 Oct 15; 3(2):185-94. PubMed ID: 6726281
    [Abstract] [Full Text] [Related]

  • 13. Synergistic activation by lymphokines and muramyl dipeptide of tumoricidal properties in rat alveolar macrophages.
    Sone S, Fidler IJ.
    J Immunol; 1980 Dec 15; 125(6):2454-60. PubMed ID: 7430635
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Synergistic generation of tumoricidal macrophages by muroctasin and interferon-gamma.
    Nagao S, Sato K, Osada Y.
    Arzneimittelforschung; 1988 Jul 15; 38(7A):999-1002. PubMed ID: 3142490
    [Abstract] [Full Text] [Related]

  • 19. Effects of liposome structure and lipid composition on the activation of the tumoricidal properties of macrophages by liposomes containing muramyl dipeptide.
    Schroit AJ, Fidler IJ.
    Cancer Res; 1982 Jan 15; 42(1):161-7. PubMed ID: 7053846
    [Abstract] [Full Text] [Related]

  • 20. Augmentation by priming with interferon-gamma of the binding of a muramyl dipeptide derivative to macrophages resulting in synergistic macrophage activation.
    Nagao S, Sato K, Osada Y.
    Jpn J Cancer Res; 1987 Jan 15; 78(1):80-6. PubMed ID: 3102442
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.